Key Takeaways
Investment in women’s health reached an all-time high in 2024, driven by growing recognition of the ways various health conditions affect women differently and disproportionately, and the causes and biological drivers behind this imbalance. While women’s health startups will face headwinds in 2025 such as investor reluctance and scarce exits, the long-term potential of the sector remains undeniable.
55% Growth in VC investment in women’s health in 2024
Total dollars invested exceeded 2023 numbers by almost $1B.
$2.6B VC investment in women’s health in 2024
When the category is expanded to include all health issues known to disproportionately affect women, the level of investment grows to $10.7B.
38% Of women’s health VC investment that went to healthtech
Healthtech still leads the women’s health sector, but its dominance is waning.
Women’s health experiences massive growth
Total VC dollars going to women’s health more than tripled between 2019 and 2024, outpacing healthcare as a whole.
This level of growth is spurred by new data and research showing how various health conditions affect women differently, leading to new treatments and medical applications.
The market moves beyond healthtech
As a proportion of total women’s health VC investment, healthtech dropped from 54% in 2021 to 38% in 2024 while biopharma skyrocketed to 35% last year, compared to 12% in 2021.
As the women’s healthcare space matures, its subsector makeup is beginning to more closely resemble the larger healthcare industry.
Investment in women’s health may be even bigger than it seems
Broadening the scope of women’s health sector to encompass conditions that disproportionately affect women brings total VC investment in women’s health to nearly $10.6B in the US and Europe.
Knowing the full scope of women’s health will help investors better evaluate comparable investments and understand the value propositions startups are bringing to the table.
Explore other SVB reports
Written and researched by SVB experts
Our deep relationships with top entrepreneurs and investors inform our insights and give us a vantage point unlike any other bank.
